Novo Holdings completed the acquisition of a 60% stake in Single Use Support.

Novo Holdings, a holding and investment company, completed the acquisition of a 60% stake in Single Use Support, a life science tools company. Financial terms were not disclosed. "Novo Holdings is joining us at a crucial moment as we prepare to further strengthen our global footprint, focusing on markets outside of Europe such as the US and Asia, and to engage with new customers. With significant insights into the life science tools sector and a comprehensive industry network, I am excited to work alongside Novo Holdings and make new strides in our shared mission of bringing better treatments to patients," Christian Praxmarer, Single Use Support CEO.